Results from a phase I/II trial of cusatuzumab combined with azacitidine in patients with newly diagnosed acute myeloid leukemia who are ineligible for intensive chemotherapy.
Haematologica
; 108(7): 1793-1802, 2023 Jul 01.
Article
en En
| MEDLINE
| ID: mdl-36779592
Texto completo:
1
Bases de datos:
MEDLINE
Asunto principal:
Leucemia Mieloide Aguda
/
Antineoplásicos
Tipo de estudio:
Clinical_trials
/
Diagnostic_studies
Límite:
Humans
Idioma:
En
Revista:
Haematologica
Año:
2023
Tipo del documento:
Article